NCT01626963

Brief Summary

Conventional multi-port laparoscopic surgery (CL) is now a standard approach to colorectal resections, due to it's short-term benefits over conventional open surgery. In recent years, several studies have demonstrated that - in suitable patients - single-port access surgery (SPA) has similar clinical outcome compared to CL, with additional cosmetic benefits. It remains, however, unclear whether the trauma of surgery is also less for SPA compared to CL. In this study, the investigators aim to randomise patients who are deemed suitable for SPA surgery to either SPA approach, or CL; in addition to clinical outcomes including length of operating time, post-operative pain scores, complications, quality of life indicators and cosmetic appearance, the investigators aim to compare the physiological response to trauma through biochemical markers (including C-reactive protein, White Blood Cell count) and cytokine expression (i.e. Interleukins IL-6 and IL-8). Patients will be analysed according to intention-to-treat analysis, with 25 patients in the SPA and 25 patients in the CL group. The patients will be operated by surgeons proficient in both CL and SPA surgery, and followed-up for the duration of their hospitalisation as well as at their routine out-patient visits, using questionnaires.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P50-P75 for phase_1 colorectal-cancer

Timeline
Completed

Started Jan 2014

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 18, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 25, 2012

Completed
1.5 years until next milestone

Study Start

First participant enrolled

January 1, 2014

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

March 24, 2016

Status Verified

March 1, 2016

Enrollment Period

2.5 years

First QC Date

June 18, 2012

Last Update Submit

March 22, 2016

Conditions

Keywords

single-port accesslaparoscopic surgerysurgical trauma

Outcome Measures

Primary Outcomes (1)

  • Operative Time

    Operative Time

    assessment of electronic records at 30 days from surgery

Secondary Outcomes (10)

  • Pain scores

    change from baseline at 1,2,3,4 and 5 days from surgery

  • Complication / Conversion-to-open-surgery rates

    assessment at 30 days post-op

  • Quality of Life indicators

    change from baseline at 2, 4 weeks, & 3 months after surgery

  • Cosmetic appearance

    change from baseline at 2, 4 weeks and three months after surgery

  • Cost comparison

    assessment at the end of the study, up to 2 years post-op

  • +5 more secondary outcomes

Study Arms (2)

SPA

EXPERIMENTAL

Single-port access surgery

Procedure: Single-port access surgery

CL

ACTIVE COMPARATOR

Conventional Laparoscopic access

Procedure: Conventional Laparoscopic Access

Interventions

Surgery carried out through a single incision laparoscopic approach

SPA

Surgery through standard multiport laparoscopic approach

CL

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • large bowel disorder requiring surgical resection
  • body habitus suitable for single-port access surgery

You may not qualify if:

  • patients not capable of informed consent and/or quality of life assessment
  • planned open procedure for surgical reason
  • multiple previous abdominal operations
  • body-mass index \> 40

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital North Tees

Stockton-on-Tees, TS19 8PE, United Kingdom

RECRUITING

MeSH Terms

Conditions

Colorectal NeoplasmsInflammatory Bowel DiseasesDiverticular Diseases

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesGastroenteritis

Central Study Contacts

David W Borowski, MD FRCSEd

CONTACT

Talvinder S Gill, MS FRCS

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant General and Colorectal Surgeon

Study Record Dates

First Submitted

June 18, 2012

First Posted

June 25, 2012

Study Start

January 1, 2014

Primary Completion

July 1, 2016

Study Completion

December 1, 2016

Last Updated

March 24, 2016

Record last verified: 2016-03

Locations